These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37739953)

  • 21. A thiol-based intramolecular redox switch in four-repeat tau controls fibril assembly and disassembly.
    Weismiller HA; Holub TJ; Krzesinski BJ; Margittai M
    J Biol Chem; 2021 Sep; 297(3):101021. PubMed ID: 34339733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.
    Trzeciakiewicz H; Tseng JH; Wander CM; Madden V; Tripathy A; Yuan CX; Cohen TJ
    Sci Rep; 2017 Mar; 7():44102. PubMed ID: 28287136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy.
    Tracy TE; Gan L
    Bioessays; 2017 Apr; 39(4):. PubMed ID: 28083916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hsp70 alters tau function and aggregation in an isoform specific manner.
    Voss K; Combs B; Patterson KR; Binder LI; Gamblin TC
    Biochemistry; 2012 Jan; 51(4):888-98. PubMed ID: 22236337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.
    Murugan NA; Nordberg A; Ågren H
    ACS Chem Neurosci; 2021 Jul; 12(13):2437-2447. PubMed ID: 34152739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly of recombinant tau into filaments identical to those of Alzheimer's disease and chronic traumatic encephalopathy.
    Lövestam S; Koh FA; van Knippenberg B; Kotecha A; Murzin AG; Goedert M; Scheres SHW
    Elife; 2022 Mar; 11():. PubMed ID: 35244536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemistry and molecular biology of tauopathies.
    Hasegawa M
    Neuropathology; 2006 Oct; 26(5):484-90. PubMed ID: 17080729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer's Disease and Other Tauopathies.
    Altendorf T; Gering I; Santiago-Schübel B; Aghabashlou Saisan S; Tamgüney G; Tusche M; Honold D; Schemmert S; Hoyer W; Mohrlüder J; Willbold D
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atomic insights into the inhibition of R3 domain of tau protein by epigallocatechin gallate, quercetin and gallic acid.
    Tang J; Sun R; Wan J; Xu Z; Zou Y; Zhang Q
    Biophys Chem; 2024 Feb; 305():107142. PubMed ID: 38088006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance.
    Cook C; Carlomagno Y; Gendron TF; Dunmore J; Scheffel K; Stetler C; Davis M; Dickson D; Jarpe M; DeTure M; Petrucelli L
    Hum Mol Genet; 2014 Jan; 23(1):104-16. PubMed ID: 23962722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular factors modulating the mechanism of tau protein aggregation.
    Fontaine SN; Sabbagh JJ; Baker J; Martinez-Licha CR; Darling A; Dickey CA
    Cell Mol Life Sci; 2015 May; 72(10):1863-79. PubMed ID: 25666877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 14-3-3/Tau Interaction and Tau Amyloidogenesis.
    Chen Y; Chen X; Yao Z; Shi Y; Xiong J; Zhou J; Su Z; Huang Y
    J Mol Neurosci; 2019 Aug; 68(4):620-630. PubMed ID: 31062171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation.
    Xia Y; Bell BM; Giasson BI
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of tau aggregation inhibitors for Alzheimer's disease.
    Bulic B; Pickhardt M; Schmidt B; Mandelkow EM; Waldmann H; Mandelkow E
    Angew Chem Int Ed Engl; 2009; 48(10):1740-52. PubMed ID: 19189357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Simulations Reveal Distinct Energetic and Kinetic Binding Properties of [
    Künze G; Kümpfel R; Rullmann M; Barthel H; Brendel M; Patt M; Sabri O
    ACS Chem Neurosci; 2022 Jul; 13(14):2222-2234. PubMed ID: 35762647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Polymerase δ-Interacting Protein 2 (PolDIP2) Inhibits the Formation of Human Tau Oligomers and Fibrils.
    Kasho K; Krasauskas L; Smirnovas V; Stojkovič G; Morozova-Roche LA; Wanrooij S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3zeta protein.
    Sadik G; Tanaka T; Kato K; Yanagi K; Kudo T; Takeda M
    Biochem Biophys Res Commun; 2009 May; 383(1):37-41. PubMed ID: 19324008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.